Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Sep 9;155:110677. doi: 10.1016/j.mehy.2021.110677

High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection

Pauline McDonagh Hull a,, Bonnie M Lashewicz a, Marvin J Fritzler b
PMCID: PMC8426136  PMID: 34560443

Abstract

The body’s innate and acquired immune systems are critical in responses to a wide spectrum of assaults, including SARS-CoV-2 infection. We identify studies of autoimmunity to support our hypothesis that a high intelligence quotient (IQ) may put children at increased risk for severe COVID-19 sequelae; especially those whose viral load is high and/or who develop multisystem inflammatory syndrome in children (MIS-C). MIS-C is associated with a higher risk of COVID-19 morbidity and death, even in otherwise healthy children. As information and evidence about SARS-CoV-2 infection continue to expand, our hypothesis suggests adding a potentially intriguing piece to the pandemic puzzle for further investigation. Drawing on a select review of published research and case reports, we discuss immune dysregulation in paediatric patients with a high IQ, including post-infection cytokine expression in the myocardium. Further, we provide a review of 27 paediatric (≤19 years; median age 16) cases of severe COVID-19 outcomes, drawn from media sources published between March and September 2020, in which we identify possible evidence of a ‘hyper brain, hyper body’ response to infection. We aver these cases are noteworthy given that paediatric death with COVID-19 disease is remarkably rare, and the estimated prevalence of a high IQ (or giftedness) is only 2% in the general population. These observations warrant prospective and retrospective studies of autoinflammatory markers and mechanisms to elucidate any special psychoneuroimmunological vulnerability in children with a high IQ, as such studies may raise implications for how and when prophylactic medical care is provided to children.

Keywords: Intelligence, IQ, Gifted, Paediatric, COVID-19, Coronavirus, SARS-C0V-2

Introduction

As global deaths due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) surpass 2 million [1], epidemiological analyses indicate that severe paediatric morbidity and mortality outcomes from COVID-19 are rare compared to such outcomes among (especially older) adults [2]. Yet once hospitalized, the percentage of ICU admission is similar for children and adults (33.2% and 32%, respectively) [3]. For researchers, an “essential question is why MIS-C develops in some paediatric patients in this age group and not in others” [4]. The reopening of schools [5] heightened efforts to identify contributory factors in the experience of children most seriously affected by COVID-19. Using evidence of inflammatory responses to SARS-CoV-2 infection (including research on autoimmune dysregulation and post-infection cytokines) to guide a review of reports of individual paediatric cases, we hypothesize that conducting prospective and retrospective studies of one potentially vulnerable paediatric cohort is warranted; namely, children with a high intelligence quotient (IQ), defined as being in the 98th percentile (or above) of the general population.

Early in the pandemic, there was consensus that the innate immune system has a critical role in the inflammatory response to SARS-CoV-2 infection [6]. Patients who develop cytokine storm syndrome (when their body overreacts in attempting to fight viral infection, and attacks its own cells and tissues instead; “an immune system gone wild” [7]) have greater disease severity and poorer outcomes [8]. In April 2020, multisystem inflammatory syndrome in children (MIS-C) (also called paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS)) [9], presenting with some similar features to those of Kawasaki disease [10], was first reported. Researchers subsequently advised that controlling the host’s inflammatory response “may be as important as targeting the virus” [11]. Specifically, “immune dysregulation” was implicated in MIS-C [5] and described as one of “the hallmarks of COVID-19” [12]. A dysregulated immune response has also been implicated in acute myocarditis, which is particularly challenging to diagnose and treat [13]. Cytokine expression in the myocardium following viral infection can lead to a dysregulated inflammatory process and sudden cardiac death [14], and this is a notable feature of many otherwise healthy children who develop MIS-C [15]. Evidence in scholarly publications and national government datasets suggest children with severe COVID-19 outcomes (including death) often present with MIS-C 1–4 weeks after infection [4], [10], and there is also research [16] to support the theory that once infected, and even though asymptomatic and without pain, their immune responses may be overreacting during this pre-clinical period of delay.

Evidence of an association between a high IQ and immune dysregulation in children was reported some decades prior to the SARS-CoV-2 pandemic [17]. While no large paediatric studies on this have been conducted since, Karpinski et al. published a study in 2018 of nearly 4000 adult Mensa participants, and concluded that a high IQ is associated with a higher risk of physiological diseases “related to immune dysregulation” [18]. Citing studies that investigated interleukin levels, cytokines and immune cells, they theorized that “If these individuals take in their world in such an overexcitable manner intellectually (hyper brain), then the potential exists for an intense level of physiological processing as well (hyper body).” They explained how the idea of ‘hyper brain, hyper body’ connections is rooted in the work of the Polish psychiatrist and psychologist Kazimierz Dabrowski, who described a tendency for “hyper-reactions and intensities to occur with greater frequency and of greater strength in the intellectually gifted compared to those with a normal or lower IQ”; these children have “overexcitabilities”. In particular, “bright individuals tended to be “neurotically allergic or nervous,” a condition which he observed to be relatively absent in the intellectually delayed.” Importantly, individuals with a high IQ demonstrated a “uniquely heightened way of experiencing and responding to their environment within five domains: psychomotor, sensory, intellectual, imaginational, and emotional.” These domains encompass psychologist Howard Gardner’s theory of “multiple intelligences”: linguistic, logical-mathematical, spatial, musical, bodily-kinesthetic, interpersonal, intrapersonal, naturalist, and existential [19]. Also described as visual/spatial [20], psychomotoric [21] and sensorimotor [22], they include artistic and athletic giftedness.

Evidence to support our hypothesis

Sparked by media reports of severe COVID-19 outcomes in children where a high IQ was indicated, we investigated further evidence for potential SARS-CoV-2 vulnerabilities in paediatric (age 19 years or younger) patients with a high IQ by conducting a search of the National Center for Biotechnology Information (NCBI) developed PubMed database, from the National Library of Medicine (NLM). A scanning search [23] using the terms ‘high IQ’ or ‘gifted’ and ‘COVID-19′, ‘SARS-CoV-2′ or ‘coronavirus’ yielded no results, so we turned our attention to a detailed review of published news and social media reports. In addition to tracking national and international reports of severe paediatric outcomes with COVID-19, we conducted weekly online Google searches, between March 15 and September 30, 2020, using search term combinations that included ‘child’, ‘children’, ‘youth’, ‘death’, ‘died’, ‘COVID-19′ and ‘coronavirus’, in conjunction with the names of countries or US states. Only news and social media reports of cases of individuals aged ≤19 years, with no reported pre-existing conditions other than autoimmune disorders, were included. We then screened for evidence of a high IQ using proxy terms such as “bright”, “talented” or “intelligent”. We also treated terms that denoted athletic intelligence (psychomotor [18], bodily-kinesthetic [19]), such as “star athlete”, as evidence indicative of a high IQ. When reports of severe paediatric outcomes did not provide evidence indicative of a high IQ but included identifying information (notably the child’s name), we conducted further Google and social media searches (via Facebook, Twitter and Instagram, including personal correspondence via these platforms) to investigate evidence of a high IQ. In total, we found news and social media reports of 27 children and adolescents with evidence indicative of a high IQ who experienced severe COVID-19 outcomes (including 20 deaths) during the pandemic, as presented in Table 1 . These reports originated from four countries, with 24 of the 27 from the United States of America. They include 15 females and 12 males aged 3–19 years (median 16). A positive test result for COVID-19 was reported in 22 of the 27 cases (three post-mortem), two tested negative, one child was not tested, and two were not reported.

Table 1.

News and social media reports of severe paediatric COVID-19 outcomes from March 15 to September 30 2020.

Evidence of a high IQ Age(sex) Country Outcome COVID-19 test Information source(s)
“a bright little girl” 3 (female) USA Death (COVID-19) Positive (post-mortem) New York Daily News [1]
“very bright” “smart little cookie” 5 (female) USA Death (COVID-19; developed rare form of meningitis and brain swelling; died <2 weeks after on ventilator) Positive ABC News [2]
“a very intelligent and mature girl for her age” “learning English at lightning speed” 6 (female) USA Death (COVID-19) Positive Tampa Bay Times [3]
“intelligent” “bright” 8 (female) USA Death (COVID-19; anosmial, died 4 days after testing positive) Positive News Observer [4]
“A smart child” “phenomenal” 9 (female) USA Death (COVID-19) Positive (post-mortem) CNN [5], Obituary [6]]
“a curious student” “what you want every student to be” “lover of books… always sneaking in extra reading time during classes, even during math” “leader” 9 (female) USA Death (COVID-19; paralysis in her arms and legs; brain inflammation) Positive WLWT [7], The Highland County Press [8], Spectrum News 1 [9]
“a straight A student” “cares a lot about school” “when she woke up, she was so concerned about the assignments she had missed” “overly worried about it” 12 (female) USA Recovered (COVID-19 and adenovirus infection; fulminant myocarditis; heart attack required CPR) Positive The Detroit News [10], Personal correspondence
“athletic, intelligent, funny, and mature” “voted Class President” “passion for swimming, competitive speaking on the Speech and Debate team” “playing viola in the orchestra” 13 (male) USA Death (initially reported as COVID-19; autopsy noted cardiac tamponade**) Negative ABC News [11], GoFundMe [12], Los Angeles County Medical Examiner-Courier [13], Claremont Courier [14]
“Imagination unbounded” “danced instead of walked most times” “had dreams, big ones and would’ve accomplished them” 13 (female) USA Death (COVID-19; comorbidity scleroderma) Positive (post-mortem) Stars and Stripes [15], The Lawton Constitution [16]
“a precocious talent” “a talented futsal player” 14 (male) Portugal Death (COVID-19; comorbidity psoriasis) Positive New Zealand Herald [17]
Attends a high school with an admissions exam, requirements for academic excellence, and 100% graduation rate 14 (male) USA Recovered (COVID-19 and heart failure, hand rash, abdominal pain, high fever one week later, sore throat; swollen neck, nausea, cough, dysgeusia) Positive New York Times [18], Author research
“beyond her years” “might’ve been 15, but you would’ve thought she was about to graduate” “a leader” “had a bright future ahead of her” 15 (female) USA Death (COVID-19; MIS-C) Negative The Baltimore Sun [19]
“an avid learner” “very bright” “high honors” “unique” “super imaginative” “an amazing student” “a leader” “she was ‘that student.’” 15 (female) USA Death (COVID-19 not tested for; died overnight; cause of death “cardiac arrhythmia of undetermined etiology”) Not tested Press Herald [20], Office of Chief Medical Examiner correspondence
“bright” “ambitious” 16 (female) France Death (COVID-19; intensive care; complained “my heart hurts”; initial negative test then positive) Negative and Positive Daily Mail [21]
“on all the sports teams” Selected for regional math team competition (5th place out of 53 schools). 16 (male) USA Recovered (COVID-19; critically ill in hospital for one month; on ECMO and life support) Positive The Washington Post [22], Alexandria Times [23], Author research
“football player who dreamed of turning pro” “wanted to… get to the NFL” 17 (male) USA Death (COVID-19 leading to heart failure; had lymphohistiocytic and eosinophilic myocarditis, severe cadiomegaly) Positive New York Post [24], The New Orleans Advocate [25]
“exceptional” “National Honors Society inductee” “had so much going on for her,… future was bright” 17 (female) USA Death (COVID-19; died two weeks after testing positive; found unresponsive in home) Positive BuzzFeed [26], NBCDFW [27]
“extremely bright” “schedule was vigorous – top academic courses, including organic chemistry” “She picked up things so fast” 18 (female) USA Death (COVID-19) Not reported The Citizens’ Voice [28]
“excelled in math and science” 18 (female) USA Death (COVID-19; born with genetic immune deficiency) Positive Daily Mail [29]
“artistic talents in abundance” “She danced, she drew, she sang, she sculpted” “so sensitive” “so talented” “so much potential“ 18 (female) USA Death (COVID-19; comorbidity systemic lupus, eczema; initially experienced chest pain, cough, fever; on ventilator) Positive Education Week [30], CBS News [31]
“phenomenal ability” “DEAN'S LIST (3.5–3.99)” “Offensive Player of the Year” 18/19 (male) USA Recovered (COVID-19 (diagnosed with heart condition after testing positive) Positive Spartanburg Herald-Journal [32], Georgia State Sports [33], Spartanburg Herald-Journal [34]
“earned a weighted GPA well above a 4.0” “school’s scholar athlete of the year” “a killer trumpet player” “honors student” “completed high school early” 18/19 (male) USA Recovered (COVID-19 (virus hit “very hard compared to most of his teammates”, ER with breathing issues, 14 days battling, one of worst cases, now possible heart disease and additional sequelae) Positive Sports Illustrated [35], The Huddle [36]
“star athlete” 19 (male) USA Death (COVID-19) Not reported K5 News [37]
“a talented basketball player” “all-time leading scorer” “member of the 2018 USSSA National Championship team” 19 (male) USA Death (COVID-19; “incredibly tired for two weeks… it was secretly attacking his body in a way they have never seen before”) Positive WFRB [38], New York Times [39]
“Star athlete” “demonstrated academic and athletic perseverance” 19 (male) Canada Death (COVID-19) Positive CBC [40]
“Great student. Great athlete” “played football, baseball and track” “named the homecoming king his senior year” 19 (male) USA Recovered (COVID-19 (mild symptoms for about a week, then chills, body aches, high fever, open-heart surgery, existing heart malformation found and valves on verge of failure) Positive, Negative and Positive GoFundMe [41], The Fresno Bee [42]
“graduated early” “[football] scholarship” 19/20 (male) USA Recovered. COVID-19 (harrowing experience, battled virus for 3 weeks, lost 14 lb) Positive Twitter [43], Sports Naut [44]

*One paediatric MIS-C study reported that almost a third of 186 patients tested negative for SARS-CoV-2 but had detectable antibodies [4].

**There is cause for questioning whether the autopsy and negative COVID-19 test confirms no SARS-CoV-2 infection. The child died 12 days after becoming ill [16]; other cardiac tamponade cases [24], including a negative test result [25], have been reported during the pandemic; and TGFBR1 gene mutation (noted in the child’s autopsy as ‘Other Significant Condition’) is increased with Il-6 [26].

Support for our hypothesis

Information and evidence about SARS-CoV-2 infection continue to expand, and our observations are intended to support our hypothesis and add a potentially intriguing piece to the pandemic puzzle: that for some children, a high IQ may be associated with an increased risk for severe COVID-19 sequelae, especially if their viral load is high [12]. The studies we review below illuminate the critical problem with overproduction of interleukin-6 (IL-6); similarities between MIS-C and paedatric Kawasaki disease; and the autoimmune association between Parkinson’s disease, high IQ, and other features of immune dysregulation. These studies explain the role of IL-6 in promoting effective cell-mediated immune responses and facilitating successful virus clearance, and the risk of myocarditis in exceptional young athletes. The most relevant studies are summarized in Table 2 , and our hypothesis about a potential association between high IQ and severe paediatric outcomes with COVID-19, as supported by the studies cited in Table 2, is represented in Fig. 1 .

Table 2.

Most relevant studies cited that support a potential association between a high IQ and severe paediatric COVID-19 outcomes.

Reference Author(s) Year Study Title Journal
11 Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP 2020 The trinity of COVID-19: immunity, inflammation and intervention Nature Reviews Immunology
15 Jain S, Nolan SM, Singh AR, et al. 2020 Myocarditis in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) Cardiology in Review
17 Benbow CP 1985 Intellectually gifted students also suffer from immune disorders Behavioral and Brain Sciences
18 Karpinski RI, Kinase Kolb AM, Tetreault NA, Borowski TB 2018 High intelligence: A risk factor for psychological and physiological overexcitabilities Intelligence
36 Segerstrom SC, Reed RG, Scott AB 2017 Intelligence and Interleukin-6 in Older Adults: The Role of Repetitive Thought Psychosomatic Medicine
44 Carlsson E, Frostell A, Ludvigsson J, Faresjö M 2014 Psychological Stress in Children May Alter the Immune Response Journal of Immunology
46 Eren F, Ömerelli Çete A, Avcil S, Baykara B 2018 Emotional and Behavioral Characteristics of Gifted Children and their Families Archives of Neuropsychiatry
50 Yıldız S, Altay N, Kılıcarslan-Toruner E 2017 Health, Care and Family Problems in Gifted Children: A Literature Review Journal for the Education of Gifted Young Scientists
51 Morey JN, Boggero IA, Scott AB, Segerstrom SC 2015 Current Directions in Stress and Human Immune Function Current Opinion in Psychology
52 Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD 2016 Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness Psychopharmacology (Berl)
54 Hughes HK, Mills Ko E, Rose D, Ashwood P 2018 Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders Frontiers in Cellular Neuroscience
56 Crespi BJ 2016 Autism As a Disorder of High Intelligence Frontiers in Neuroscience
57 Leitner Y 2014 The Co-Occurrence of Autism and Attention Deficit Hyperactivity Disorder in Children - What Do We Know? Frontiers in Human Neuroscience
58 Cordeiro ML, Farias AC, Cunha A, et al. 2011 Co-Occurrence of ADHD and High IQ: A Case Series Empirical Study Journal of Attention Disorders
59 Pfeiffer SI 2015 Gifted students with a coexisting disability: The twice exceptional Estudos de Psicologia
76 Fardell C, Torén K, Schiöler L, Nissbrandt H, Åberg M 2020 High IQ in Early Adulthood Is Associated with Parkinson's Disease Journal of Parkinson’s Disease
79 Schneider W, Niklas F, Schmiedeler S 2014 Intellectual development from early childhood to early adulthood: The impact of early IQ differences on stability and change over time Learning and Individual Differences
80 Nazarenko LD 2013 The Role of Intelligence in Sport Teorija i praktika fiziceskoj kul'tury
85 Deary IJ, Batty GD 2007 Cognitive epidemiology Journal of Epidemiology and Community Health
86 Louveau A, Smirnov I, Keyes TJ, et al. 2015 Structural and functional features of central nervous system lymphatic vessels Nature

Fig. 1.

Fig. 1

Intersections of studies cited that support a potential association between a high IQ and severe paediatric COVID-19 outcomes.

The role of interleukin-6 overproduction in SARS-CoV-2 infection

Interleukin-6 (IL-6) is a pleotropic cytokine with a key role in regulating the body’s immune response to viruses, and its overexpression is associated with immune system dysregulation [27]. Macrophage activation syndrome (MAS), which is related to hemophagocytic lymphohistiocytosis (HLH), is a rare complication of systemic juvenile idiopathic arthritis (SJIA), an autoimmune paediatric disease where increased levels of IL-6 correlate with disease activity [28]. Increased levels of IL-6 are noted with juvenile systemic lupus erythematosus (jSLE) [29], [30], and have been used as a potential biomarker in the treatment of paediatric patients with non-juvenile idiopathic arthritis [31]. Elevated IL-6 levels have also been associated with increased disease severity in influenza virus infections; H1N1 influenza A [32], SARS-CoV-1 [27], and numerous paediatric cases with SARS-CoV-2 [33], including MIS-C [9], [34], [35]. A recent study to investigate an association between IL-6 levels and IQ (albeit in older adults; mean age 74 years) reported an association with low levels of IL-6 and a high IQ [36], unlike the high IL-6 levels reported with MIS-C. However, the properties of IL-6 depend on its transduction pathway in the body (anti-inflammatory or pro-inflammatory) [27], and in this regard, the relevance of the vital role played by T cells in regulating the body’s immune response to viral infections like COVID-19 is important to understand [37].

In the first week of infection, SARS-CoV-2 activates T cells, including virus-specific memory CD4+ cells that peak within two weeks, and remain detectable for a longer period in up to 100% of COVID-19 patients [38]. Long-lived memory T and B cells are a key feature of autoimmune diseases such as jSLE and lupus nephritis (LN), to name two, and in jSLE, an association with pro-inflammatory cytokines is evident [39], [40]. Of relevance, given the evidence linking IL-6 and a high IQ, recent reports indicate that “SARS-CoV-2-specific T cells” and “long-lasting memory T cells” may have a protective effect in patients recovering from COVID-19, and those who have never contracted the disease [41]. A 2008 study of H17 influenza virus in rodents reported that the activity of CD4+ T cells “diminished in the absence of IL-6”, thereby compromising protective anti-viral immunity. When the virus activated dendritic cells (which process and present antigen to T cells), high levels of IL-6 were produced [42]. Essentially, too little IL-6 prior to infection could increase susceptibility and risk of complications, with a rebound or overshoot of increased IL-6 and other pro-inflammatory cytokines resulting in the autoinflammatory phase of the disease (COVID-19 cytokine storm; MIS-C). This serves as an explanation of why low levels of IL-6, and therefore a high IQ, may increase the risk of COVID-19 and/or MIS-C, making high IQ, alongside the established role of elevated IL-6 [43], a potential socio-demographic marker for poor outcomes.

Paediatric evidence of immune dysregulation with high IQ, stress and autism spectrum disorder

Acting as a pro-inflammatory cytokine, IL-6 is also elevated by psychological stressors, such as depression, with “an increased secretion” found in “high-stressed children” [44]. The SARS-CoV-2 pandemic has been reported as posing significant psychological health risks to all children [45], but evidence suggests that a high IQ may increase those risks [46], [47]. Dabrowski included “imaginational, and emotional domains” in his description of multiple intelligences in individuals with a high IQ [18], and other researchers have suggested these individuals are “more sensitive to existential issues” [48]. One report on suicide in children with a high IQ described them as “understanding adult situations and world events but being powerless to affect their outcomes” [49]. Some perceived “problems that the world created” as “catastrophic”, and their “solution was to remove all the problems, all at once”. Correspondingly, a recent literature review exploring health, care and family problems in gifted children found “emotional problems” were most common (a rate of 81%) [50], which implies a heightened level of stress associated with a high IQ. The review found “no signs of physical health and care problems” (though notably, its search terms included ‘gifted/talented children’ but not ‘high IQ’ or ‘intelligence’), yet psychologists have argued that psychological stress can have a physical effect, by dysregulating the immune system [51]. Supporting our hypothesis, the role of acute stress in exacerbating pro-inflammatory cytokine induction [52] points to a potential special psychoneuroimmunological vulnerability in children with a high IQ.

Furthermore, based on the increased risk of inflammation and immune dysregulation reported in children with autism spectrum disorder (ASD) [53], [54], researchers have been prompted to examine whether ASD could be a paediatric risk factor for SARS-CoV-2 [55]. This may be particularly relevant to our hypothesis given a recent synthesis report that proposed a genetic connection between ASD and a high IQ (“autism as a disorder of high intelligence” [56]). Offering “new insights and research questions into the nature and inter-relationships of intelligence, autism, and schizophrenia”, the article cited genetic studies suggesting common alleles “for” autism “overlap substantially and significantly with alleles “for” high intelligence”. Given these shared alleles, together with evidence of a high IQ co-occurrence in some children with attention deficit hyperactivity disorder (ADHD) [58] (a condition commonly co-existing in children with ASD [57]), it is plausible that children with a high IQ and ASD (“the twice exceptional” [59]) may also have shared, or overlapping, inflammatory vulnerability to SARS-CoV-2 infection.

Identifying similarities between autoimmune diseases and COVID-19

Based on reports of antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease, a “crossroad” of autoimmunity and SARS-CoV2 infection has been a topic of considerable interest to researchers (reviewed by Rodríguez Y et al. [60]). Early connections between COVID-19 outcomes and MIS-C highlighted similarities with the acute multisystem inflammatory Kawasaki disease, one of the most common causes of acquired heart disease in children. Our review did not find an association between paediatric Kawasaki disease and a high IQ, other than noting a significantly higher incidence of the disease in South Asian countries (highest in Japan [61]), which rank top in international IQ lists [62]. Of relevance however, levels of IL-6 can be significantly higher when Kawasaki disease patients develop (even rarer) Kawasaki disease shock syndrome (KDSS) [63], such that treatment strategies stress the importance of “Ending powerful inflammation in the acute phase as early as possible” [64].

Kawasaki disease typically has long-term health repercussions. In research by King et al., 34% of families reported “a lasting effect”, and described some affected children as “having significantly more attention difficulties” [65]. This is similar to reports of long-lasting COVID-19 symptoms of “prolonged fatigue” and “brain fog” [66], including reports in the form of anecdotal evidence of long-lasting COVID-19 symptoms occurring in children [67]. Reports of “Difficulty thinking” following SARS-CoV-2 infection have been cast in terms of concerns that the virus “may damage brain cells” [68]. King et al. also recommended lifetime cardiovascular management following Kawasaki disease [69], echoing concerns related to dysregulated immune response and acute myocarditis with COVID-19.

One more eponymous autoimmune disease to receive attention during the pandemic is Parkinson’s disease  [70], [71], which can present with increased levels of pro-inflammatory cytokines in the brain, including IL-6 [72] and immune dysregulation [73]. Over the course of the 1918 Spanish flu pandemic, there was “a 2–3-fold-increased risk” of Parkinson’s disease [74], and in October 2020, Israeli physicians reported a single case of probable parkinsonism following SARS-CoV-2 infection [75]. Moreover, Swedish research published in the same month identified high IQ as a risk factor for Parkinson’s disease [76], which reiterates previous findings reliant on occupational complexity measures [77], [78]. Given that a high IQ is relatively stable from child to adulthood [79], this lends support to a potential association between high IQ and immune dysregulation following viral infection.

Evidence of myocarditis with high athletic intelligence

In several of the paediatric cases of severe COVID-19 outcomes that we present in Table 1, the children were described as exceptionally talented athletes who experienced severe cardiac complications after SARS-CoV-2 infection. In the context of our hypothesis, and the ‘hyper brain, hyper body’ paradigm, we treat these cases as reflecting a high physical IQ [80] or high psychomotor [18], bodily-kinesthetic [19] intelligence; they are “exceptionally gifted” athletes [22] with “high performance brains, as well as bodies” [81]. Between June and August 2020, a group of doctors in the USA performed cardiac magnetic resonance imaging on 26 competitive college athletes recovering from COVID-19 disease, and reported that 15% had “findings suggestive of myocarditis” [82]. None of the athletes tested required hospitalization when infected, but these results convinced the country’s Pac-12 and Big Ten collegiate conferences to postpone games in the fall, and some top-flight collegiate players opted out entirely. Another US study of 54 student athletes recovering from asymptomatic, mild or moderate symptoms of COVID-19 reported a high prevalence of late pericardial enhancement [83]. Given doctors’ warnings of exercise-induced accelerated viral replication and increased inflammation with COVID-19 [82], plus the unknown long-term effects after myocarditis [84], we encourage future research that considers high athletic intelligence as an independent variable.

Implications of the hypothesis

More thorough understandings of the relationship between intelligence and mortality and morbidity [85], and the connections between the brain and the immune system [86], remain relatively new fields of research. COVID-19 is a novel disease; therefore, researchers must examine paediatric risk factors with "very little evidence at our disposal" [87] and consider "other diseases with overlapping manifestations" [88]. We aver a potential special psychoneuroimmunological vulnerability may exist in children with a high IQ, and especially in those who develop MIS-C following SARS-CoV-2 infection. With the tendency for obituaries to celebrate life achievements, it may not be significant that the paediatric cases we present are indicative of a high IQ, though other published research demonstrates an association between high IQ and immune system health [14], [17]. Certainly, IQ is challenging to identify as a clinical characteristic. Educational attainment is often used as a proxy [89], but this substitute is not entirely reliable, even in schools. A focus on “academic ability or achievement” may obscure other intelligences; plus these children are “not always high achievers” [90]. Of significant concern, children in lower socioeconomic groups are less likely to be identified, and during the pandemic, are less sheltered from the virus and more adversely affected by lockdowns [91], [92]. Therefore, albeit limited by a lack of current clinical data on paediatric high IQ, testing our hypothesis through retrospective autoimmune analysis of paediatric MIS-C cases, using proxies where necessary, would provide valuable information. Furthermore, with IQ remaining relatively stable into adulthood [79], our hypothesis also warrants exploration among adult patient populations.

Numbers of severe paediatric COVID-19 outcomes worldwide are currently very small (a near zero mortality rate [93]; 0.07% children have died in the USA [94]) and an estimated 2% of the general population has a high IQ [15], [85]. Via media reports alone, our review identified 27 cases where evidence of a high IQ was indicated (including 17 deaths in the USA, or 15% of the total 112 deaths reported there by October 1, 2020 [94]). Autoinflammatory evidence suggests IL-6 may amplify paediatric response to infections and contribute to a cytokine storm, and some researchers suggest, “Early detection of children with mild symptoms or an asymptomatic state, and early diagnosis of MIS-C are mandatory for the management of COVID-19 and the prevention of transmission and a severe inflammatory state” [95]. Similarly, Karpinski et al. argued the beneficial impact of understanding the relationship between high IQ and illness, and recent SJIA studies report a very low rate of MAS episodes (or milder disease) in children who were prescribed an IL-6 monoclonal antibody [28]. Therefore, in the context of SARS-CoV-2 infection, and the benefits of timely action, our hypothesis extends the challenge to increase awareness of high IQ as a potentially identifiable paediatric characteristic in immune dysregulation, exacerbated inflammatory response and COVID-19 disease susceptibility. It raises implications for how and when prophylactic medical care is provided to children. Further investigation should help clarify the evidence cited here, and may support efforts to save lives.

Funding

This research was not funded. Dr. Lashewicz’s Social Sciences and Humanities Research Council (SSHRC) grant number 435-2019-094 will cover open access publishing costs.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

Acknowledgments

We acknowledge the parents who have shared health information about their children publicly, and the cited news agencies for enabling access to their reports. We acknowledge the Office of Chief Medical Examiner in Augusta, Maine for providing cause of death for one of the cases cited.

Data availability statement

The datasets analyzed for this study can be found in Table 1.

Author contributions

PMH conceived of the study; PMH conducted the reviews and wrote the manuscript report drafts; MJF and BML provided study design advice and oversight; PMH, BML and MJF edited the manuscripts; all read and approved the final submission.

Consent statement/ethical approval

Not required.

References

  • 1.World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard (2021). https://covid19.who.int/ [accessed March 8, 2021].
  • 2.Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ (2020) doi:10.1136/bmj.m3249. [DOI] [PMC free article] [PubMed]
  • 3.Centers for Disease Control and Prevention. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020 (2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e3.htm [accessed September 27, 2020]. [DOI] [PMC free article] [PubMed]
  • 4.Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. Children and adolescents. N Engl J Med (2020) doi:10.1056/NEJMoa2021680. [DOI] [PMC free article] [PubMed]
  • 5.Yonker L.M., Neilan A.M., Bartsch Y., et al. Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses. J Pediatr. 2020 doi: 10.1016/j.jpeds.2020.08.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Li G., Fan Y., Lai Y., Han T., Li Z., Zhou P., et al. Coronavirus infections and immune responses. J Med Virol. 2020:424–432. doi: 10.1002/jmv.25685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Windsor M. UAB Reporter. Here’s a playbook for stopping deadly cytokine storm syndrome (2019). https://www.uab.edu/reporter/know-more/publications/item/8909-here-s-a-playbook-for-stopping-deadly-cytokine-storm-syndrome [accessed December 27, 2020].
  • 8.Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020:1033–1034. doi: 10.1016/S0140-6736(20)30628-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Abrams J.Y., Godfred-Cato S.E., Oster M.E., et al. Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2: a systematic review. J Pediatr. 2020 doi: 10.1016/j.jpeds.2020.08.003. [DOI] [Google Scholar]
  • 10.Ahmed M., Advani S., Moreira A., Zoretic S., Martinez J., Chorath K., et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020 doi: 10.1016/j.eclinm.2020.100527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 doi: 10.1038/s41577-020-0311-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lieberman N.A.P., Peddu V., Xie H., Shrestha L., Huang M.-L., Mears M.C., et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol. 2020 doi: 10.1371/journal.pbio.3000849. e3000849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hazebroek M., Dennert R., Heymans S. Virus infection of the heart – unmet therapeutic needs. Antivir Chem Chemother. 2012 doi: 10.3851/IMP2047. [DOI] [PubMed] [Google Scholar]
  • 14.Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis-diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015 doi: 10.1038/nrcardio.2015.108. [DOI] [PubMed] [Google Scholar]
  • 15.Jain S., Nolan S.M., Singh A.R., Lovig L., Biller R., Kamat A., et al. Myocarditis in multisystem inflammatory syndrome in children associated with coronavirus disease 2019. Cardiol Rev. 2020 doi: 10.1097/CRD.0000000000000341. [DOI] [PubMed] [Google Scholar]
  • 16.Moutal A., Martin L.F., Boinon L., Gomez K., Ran D., Zhou Y., et al. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. Pain. 2021 doi: 10.1097/j.pain.0000000000002097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Benbow C.P. Intellectually gifted students also suffer from immune disorders. Behav Brain Sci. 1985 doi: 10.1017/S0140525X00001059. [DOI] [Google Scholar]
  • 18.Karpinski R.I., Kinase Kolb A.M., Tetreault N.A., Borowski T.B. High intelligence: a risk factor for psychological and physiological overexcitabilities. Intelligence. 2018 doi: 10.1016/j.intell.2017.09.001. [DOI] [Google Scholar]
  • 19.Gardner H. Basic Books; New York, NY: 1999. Intelligence reframed: multiple intelligences for the 21st century. [Google Scholar]
  • 20.Adams S. In: Principles of programming & coding. Franceschetti D.R., editor. Salem Press; Ipswich, Massachusetts: 2013. Theory of multiple intelligences. [Google Scholar]
  • 21.Gross M.U.M. International handbook of giftedness and talent. Gift Talent Int. 2001:75–76. doi: 10.1080/15332276.2001.11672958. [DOI] [Google Scholar]
  • 22.Issurin V.B. Evidence-based prerequisites and precursors of athletic talent: a review. Sport Med. 2017:1993–2010. doi: 10.1007/s40279-017-0740-0. [DOI] [PubMed] [Google Scholar]
  • 23.Rethlefsen M.L., Kirtley S., Waffenschmidt S., Ayala A.P., Moher D., Page M.J., et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021 doi: 10.1186/s13643-020-01542-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hakmi H., Sohail A., Brathwaite C., Ray B., Abrol S. Cardiac tamponade in COVID-19 patients: management and outcomes. J Card Surg. 2020;35(11):3183–3190. doi: 10.1111/jocs.14925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Singh R., Fuentes S., Ellison H., Chavez M., Hadidi O.F., Khoshnevis G., et al. A case of hemorrhagic cardiac tamponade in a patient with COVID-19 infection. CASE. 2020:316–319. doi: 10.1016/j.case.2020.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Luckett-Chastain L.R., Cottrell M.L., Kawar B.M., Ihnat M.A., Gallucci R.M. Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes. Exp Dermatol. 2017:697–704. doi: 10.1111/exd.13260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Magro G. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? what is there besides Tocilizumab? SGP130Fc. Cytokine X. 2020:100029. doi: 10.1016/j.cytox.2020.100029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schulert G.S., Grom A.A. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014:277–292. doi: 10.1016/j.berh.2014.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cavalcanti A., Santos R., Mesquita Z., Duarte A.L.B.P., Lucena-Silva N. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study. Brazilian J Med Biol Res. 2017 doi: 10.1590/1414-431x20175738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Postal M., Peliçari K.O., Sinicato N.A., Marini R., Costallat L.T.L., Appenzeller S. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine. 2013:785–791. doi: 10.1016/j.cyto.2012.11.023. [DOI] [PubMed] [Google Scholar]
  • 31.Jung J.-Y., Kim M.-Y., Suh C.-H., Kim H.-A. Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review. Pediatr Rheumatol. 2018 doi: 10.1186/s12969-018-0296-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Paquette S.G., Banner D., Zhao Z., Fang Y., Huang S.S.H., Leόn A.J., et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection. PLoS ONE. 2012:e38214. doi: 10.1371/journal.pone.0038214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang Y, Wang Y, Zhu F, et al. Children hospitalized with severe COVID-19 in Wuhan. Pediatr Infect Dis J (2020) doi:10.1097/INF.0000000000002739. [DOI] [PubMed]
  • 34.Belhadjer Z., Méot M., Bajolle F., Khraiche D., Legendre A., Abakka S., et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020:429–436. doi: 10.1161/CIRCULATIONAHA.120.048360. [DOI] [PubMed] [Google Scholar]
  • 35.Toraih EA, Hussein MH, Elshazli RM, et al. Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis [published online ahead of print, 2021 Feb 20]. World J Pediatr. 2021;1-11. doi:10.1007/s12519-021-00419-y. [DOI] [PMC free article] [PubMed]
  • 36.Segerstrom S.C., Reed R.G., Scott A.B. Intelligence and interleukin-6 in older adults: the role of repetitive thought. Psychosom Med. 2017 doi: 10.1097/PSY.0000000000000479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cox R.J., Brokstad K.A. Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nat Rev Immunol. 2020 doi: 10.1038/s41577-020-00436-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Stephens D.S., McElrath M.J. COVID-19 and the path to immunity. JAMA – J Am Med Assoc. 2020 doi: 10.1001/jama.2020.16656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ballantine L.E., Ong J., Midgley A., Watson L., Flanagan B.F., Beresford M.W. The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. Pediatr Rheumatol. 2014 doi: 10.1186/1546-0096-12-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Edelbauer M., Kshirsagar S., Riedl M., Billing H., Tönshoff B., Haffner D., et al. Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis. J Clin Immunol. 2012 doi: 10.1007/s10875-011-9637-0. [DOI] [PubMed] [Google Scholar]
  • 41.Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A., et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020 doi: 10.1038/s41586-020-2550-z. [DOI] [PubMed] [Google Scholar]
  • 42.Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., et al. Interleukin-6 is crucial for recall of influenza-specific memory CD4 + T cells. PLoS Pathog. 2008 doi: 10.1371/journal.ppat.1000006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Herold T., Jurinovic V., Arnreich C., Lipworth B.J., Hellmuth J.C., von Bergwelt-Baildon M., et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020 doi: 10.1016/j.jaci.2020.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Carlsson E., Frostell A., Ludvigsson J., Faresjö M. Psychological stress in children may alter the immune response. J Immunol. 2014 doi: 10.4049/jimmunol.1301713. [DOI] [PubMed] [Google Scholar]
  • 45.Dalton L., Rapa E., Stein A. Protecting the psychological health of children through effective communication about COVID-19. Lancet Child Adolesc Heal. 2020 doi: 10.1016/S2352-4642(20)30097-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Eren F., Omerelli Cete A., Avcil S., Baykara B. Emotional and behavioral characteristics of gifted children and their families. Noropsikiyatri Ars. 2018 doi: 10.5152/NPA.2017.12731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Fleith DS. The National Research Center on the Gifted and Talented. Suicide Among Gifted Adolescents: How to Prevent It (2001). https://nrcgt.uconn.edu/newsletters/spring012/# [accessed December 27, 2020].
  • 48.Webb J.T. Originally presented at Dabrowski and gifted education: beyond overexcitabilities, the eighth international congress of the institute for positive disintegration in human development. 2008. Dabrowski’s theory and existential depression in gifted children and adults. [Google Scholar]
  • 49.Farrell D.M. Suicide among gifted students. Roeper Rev. 1989:134–139. doi: 10.1080/02783198909553189. [DOI] [Google Scholar]
  • 50.Altay N., Kılıcarslan-Toruner E., Yıldız S. Health, care and family problems in gifted children: a literature review. J Educ Gift Young Sci. 2017:15–24. doi: 10.17478/JEGYS.2017.62. [DOI] [Google Scholar]
  • 51.Morey J.N., Boggero I.A., Scott A.B., Segerstrom S.C. Current directions in stress and human immune function. Curr Opin Psychol. 2015:13–17. doi: 10.1016/j.copsyc.2015.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Calcia M.A., Bonsall D.R., Bloomfield P.S., Selvaraj S., Barichello T., Howes O.D. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology. 2016:1637–1650. doi: 10.1007/s00213-016-4218-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Enstrom A.M., Van De W.A.J., Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs. 2009 [PMC free article] [PubMed] [Google Scholar]
  • 54.Hughes H.K., Mills Ko E., Rose D., Ashwood P. Immune dysfunction and autoimmunity as pathological mechanisms in autism spectrum disorders. Front Cell Neurosci. 2018 doi: 10.3389/fncel.2018.00405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lima ME de S, Barros LCM, Aragão GF. Could autism spectrum disorders be a risk factor for COVID-19? Med Hypotheses (2020) doi:10.1016/j.mehy.2020.109899. [DOI] [PMC free article] [PubMed]
  • 56.Crespi B.J. Autism as a disorder of high intelligence. Front Neurosci. 2016 doi: 10.3389/fnins.2016.00300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children – what do we know? Front Hum Neurosci (2014) doi.org/10.3389/fnhum.2014.00268. [DOI] [PMC free article] [PubMed]
  • 58.Cordeiro M.L., Farias A.C., Cunha A., Benko C.R., Farias L.G., Costa M.T., et al. Co-occurrence of ADHD and high iq: a case series empirical study. J Atten Disord. 2011:485–490. doi: 10.1177/1087054710370569. [DOI] [PubMed] [Google Scholar]
  • 59.Pfeiffer S.I. Gifted students with a coexisting disability: the twice exceptional. Estud psicol. 2015:717–727. doi: 10.1590/0103-166X2015000400015. [DOI] [Google Scholar]
  • 60.Rodríguez Y., Novelli L., Rojas M., De Santis M., Acosta-Ampudia Y., Monsalve D.M., et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020:102506. doi: 10.1016/j.jaut.2020.102506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lin M.-T., Wu M.-H. The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract. 2018 doi: 10.21542/gcsp.2017.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lynn R., Vanhanen T. Ulster Institute for Social Research; London: 2012. Intelligence: a unifying construct for the social sciences; p. 552. [Google Scholar]
  • 63.Li Y., Zheng Q.i., Zou L., Wu J., Guo L.i., Teng L., et al. Kawasaki disease shock syndrome: Clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Pediatr Rheumatol. 2019 doi: 10.1186/s12969-018-0303-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ishii M., Ebato T., Kato H. History and future of treatment for acute stage Kawasaki disease. Korean Circ J. 2020:112. doi: 10.4070/kcj.2019.0290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.King W.J., Schlieper A., Birdi N., Cappelli M., Korneluk Y., Rowe P.C. The effect of Kawasaki disease on cognition and behavior. Arch Pediatr Adolesc Med. 2000:463. doi: 10.1001/archpedi.154.5.463. [DOI] [PubMed] [Google Scholar]
  • 66.Taylor T. COVID-19 long-term effects: people report ongoing fatigue, brain fog and breathlessness, so what’s happening in the body? ABC Heal Wellbeing (2020).
  • 67.Davis, H. The Guardian. Brain fog, phantom smells and tinnitus: my experience as a Covid 'long hauler' (2020). https://www.theguardian.com/commentisfree/2020/aug/05/brain-fog-phantom-smells-and-tinnitus-my-experience-as-a-covid-long-hauler [accessed December 27, 2020].
  • 68.Couzin-Frankel J. From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists. Science (80-) 2020 doi: 10.1126/science.abe1147. [DOI] [Google Scholar]
  • 69.Brogan P., Burns J.C., Cornish J., Diwakar V., Eleftheriou D., Gordon J.B., et al. Lifetime cardiovascular management of patients with previous Kawasaki disease. Heart. 2020:411–420. doi: 10.1136/heartjnl-2019-315925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Boika A.V. A Post-COVID-19 parkinsonism in the future? Mov Disord. 2020 doi: 10.1002/mds.28117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Sulzer D, Antonini A, Leta V, et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. npj Park Dis (2020) doi:10.1038/s41531-020-00123-0. [DOI] [PMC free article] [PubMed]
  • 72.Tan E.-K., Chao Y.-X., West A., Chan L.-L., Poewe W., Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol. 2020:303–318. doi: 10.1038/s41582-020-0344-4. [DOI] [PubMed] [Google Scholar]
  • 73.Chao Y., Wong S.C., Tan E.K. Evidence of inflammatory system involvement in Parkinson’s disease. Biomed Res Int. 2014:1–9. doi: 10.1155/2014/308654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Smeyne R. World Parkinson Congress Basic Science, First. The Flu and You: How Viruses Influence the Risk of Parkinson's (2017). https://www.worldpdcongress.org/home/2017/4/7/flu-and-you [accessed September 27, 2020].
  • 75.Cohen M.E., Eichel R., Steiner-Birmanns B., Janah A., Ioshpa M., Bar-Shalom R., et al. A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol. 2020:804–805. doi: 10.1016/S1474-4422(20)30305-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Fardell C., Torén K., Schiöler L., Nissbrandt H., Åberg M. High IQ in early adulthood is associated with Parkinson’s disease. J Parkinsons Dis. 2020:1649–1656. doi: 10.3233/JPD-202050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Beard J.D., Steege A.L., Ju J., Lu J., Luckhaupt S.E., Schubauer-Berigan M.K. Mortality from amyotrophic lateral sclerosis and parkinson’s disease among different occupation groups – United States, 1985–2011. MMWR Morb Mortal Wkly Rep. 2017 doi: 10.15585/mmwr.mm6627a2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Valdés E.G., Andel R., Sieurin J., Feldman A.L., Edwards J.D., Långström N., et al. Occupational complexity and risk of Parkinson’s disease. PLoS ONE. 2014 doi: 10.1371/journal.pone.0106676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Schneider W., Niklas F., Schmiedeler S. Intellectual development from early childhood to early adulthood: the impact of early IQ differences on stability and change over time. Learn Individ Differ. 2014 doi: 10.1016/j.lindif.2014.02.001. [DOI] [Google Scholar]
  • 80.Nazarenko LD. The role of intelligence in sport. Teor i Prakt Fiz Kult (2013).
  • 81.Schonbrun Z, McDonald B. CBC Radio. Great athletes have high performance brains, as well as bodies (2020). https://www.cbc.ca/radio/quirks/may-26-2018-cheating-on-the-ozone-treaty-nano-nutrients-for-crops-why-birds-almost-died-out-1.4675194/great-athletes-have-high-performance-brains-as-well-as-bodies-1.4675213 [accessed September 27, 2020].
  • 82.Phelan D., Kim J.H., Chung E.H. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020:1085. doi: 10.1001/jamacardio.2020.2136. [DOI] [PubMed] [Google Scholar]
  • 83.Brito D., Meester S., Yanamala N., Patel H.B., Balcik B.J., Casaclang-Verzosa G., et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2021 doi: 10.1016/j.jcmg.2020.10.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol (2020) doi:10.1001/jamacardio.2020.4916. [DOI] [PMC free article] [PubMed]
  • 85.Deary I.J., Batty G.D. Cognitive epidemiology. J Epidemiol Community Health. 2007 doi: 10.1136/jech.2005.039206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature (2015) doi.org/10.1038/nature14432. [DOI] [PMC free article] [PubMed]
  • 87.Sinha I.P., Harwood R., Semple M.G., Hawcutt D.B., Thursfield R., Narayan O., et al. COVID-19 infection in children. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30152-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020 doi: 10.1016/j.autrev.2020.102597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Singh-Manoux A. Commentary: is it time to redefine cognitive epidemiology? Int J Epidemiol. 2010 doi: 10.1093/ije/dyq123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Bainbridge C. How Schools May Identify a Gifted Student (2021). https://www.verywellfamily.com/what-is-a-gifted-child-1449130 [accessed March 27, 2020].
  • 91.Goyal MK, Simpson JN, Boyle MD, et al. Racial and/or ethnic and socioeconomic disparities of SARS-CoV-2 infection among children. Pediatrics (2020) doi:10.1542/peds.2020-009951. [DOI] [PubMed]
  • 92.Singu S., Acharya A., Challagundla K., Byrareddy S.N. Impact of social determinants of health on the emerging COVID-19 pandemic in the United States. Front Public Heal. 2020 doi: 10.3389/fpubh.2020.00406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Oke J, Heneghan C. The Centre for Evidence-Based Medicine (CEBM). Global Covid-19 Case Fatality Rates (2020). https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ [accessed December 17, 2020].
  • 94.American Academy of Pediatrics and the Children’s Hospital Association. Children and COVID-19: State Data Report (2020). https://downloads.aap.org/AAP/PDF/AAP%20and%20CHA%20-%20Children%20and%20COVID-19%20State%20Data%20Report%2012.17.20%20FINAL.pdf [accessed December 17, 2020].
  • 95.Yasuhara J., Kuno T., Takagi H., Sumitomo N. Clinical characteristics of COVID-19 in children: a systematic review. Pediatr Pulmonol. 2020 doi: 10.1002/ppul.24991. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets analyzed for this study can be found in Table 1.


Articles from Medical Hypotheses are provided here courtesy of Elsevier

RESOURCES